Calibration of treatment effect size through propensity score ratio reweighting
View Presentation Jianxiong Chu, The US FDA *Lei Nie, The US FDA Daniel Rubin, The US FDA Zhiwei Zhang, The US FDA Keywords: noninferiority, covariate-adjusmtnet approach, marginal and conditional treatment effect To maintain the interpretability of the experimental treatment effect obtained from noninferiority trials, current statistical approaches often rely on the constancy assumption. In practice, it has been found difficult to hold this rigorous constancy assumption. We will use a covariate-adjustment approach through propensity score matching to obtained a marginal treatment effect and will compare this approach to our original regression approach, which results a conditional treatment effect. We shall also briefly discuss criticisms (e.g. no patient level data, no pre-specification) of the covariate-adjustment approaches and possible solutions.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC